Detalles de la búsqueda
1.
Hypoxia-related carbonic anhydrase 9 induces serpinB9 expression in cancer cells and apoptosis in T cells via acidosis.
Cancer Sci
; 115(5): 1405-1416, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38413363
2.
Sex differences in lower urinary tract function in mice with or without spinal cord injury.
Neurourol Urodyn
; 43(1): 267-275, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37916422
3.
Prostate-specific antigen (PSA) decline with apalutamide therapy is associated with longer survival and improved outcomes in individuals with metastatic prostate cancer: a plain language summary of the TITAN study.
Future Oncol
; 20(10): 563-578, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38126311
4.
Urinary markers for bladder cancer diagnosis: A review of current status and future challenges.
Int J Urol
; 31(3): 208-219, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-37968825
5.
Moving toward improved immune checkpoint immunotherapy for advanced prostate cancer.
Int J Urol
; 31(4): 307-324, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38167824
6.
Real world evidence of enfortumab vedotin in patients with advanced urothelial cancer: A multicenter observational study.
Int J Urol
; 31(4): 342-347, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38113343
7.
Real-world outcomes of avelumab plus axitinib as first-line therapy in patients with advanced renal cell carcinoma in Japan: A multicenter, retrospective, observational study (J-DART).
Int J Urol
; 31(3): 265-272, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38110838
8.
Summary of the Clinical Practice Guidelines for Upper Tract Urothelial Carcinoma 2023 by the Japanese Urological Association.
Int J Urol
; 31(3): 194-207, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38113344
9.
Avelumab Plus Axitinib as First-Line Therapy for Advanced Renal Cell Carcinoma: Long-Term Results from the JAVELIN Renal 100 Phase Ib Trial.
Oncologist
; 28(4): 333-340, 2023 04 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36576173
10.
Current status and future perspectives of the managements of metastatic hormone-sensitive prostate cancer.
World J Urol
; 41(8): 2063-2068, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-36040500
11.
External beam radiotherapy combination is a risk factor for bladder cancer in patients with prostate cancer treated with brachytherapy.
World J Urol
; 41(5): 1317-1321, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-37024557
12.
The safety profile of nivolumab plus ipilimumab combination therapy in Japanese patients with renal cell carcinoma: results from post-marketing surveillance.
Jpn J Clin Oncol
; 53(8): 730-737, 2023 Jul 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-37151051
13.
Adjuvant nivolumab versus placebo following radical surgery for high-risk muscle-invasive urothelial carcinoma: a subgroup analysis of Japanese patients enrolled in the phase 3 CheckMate 274 trial.
Jpn J Clin Oncol
; 53(1): 16-25, 2023 Jan 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36300304
14.
Comprehensive investigation of clinicopathological and immunological features to determine prognostic impact in metastatic renal cell carcinoma: The JEWEL study.
Int J Urol
; 30(11): 977-984, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37434386
15.
Real-world effectiveness of nivolumab and subsequent therapy in Japanese patients with metastatic renal cell carcinoma (POST-NIVO study): 36-month follow-up results of a clinical chart review.
Int J Urol
; 30(9): 762-771, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37248753
16.
Simultaneous analysis of serum α2,3-linked sialylation and core-type fucosylation of prostate-specific antigen for the detection of high-grade prostate cancer.
Br J Cancer
; 126(5): 764-770, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34802050
17.
EphA2 on urinary extracellular vesicles as a novel biomarker for bladder cancer diagnosis and its effect on the invasiveness of bladder cancer.
Br J Cancer
; 127(7): 1312-1323, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35794239
18.
Apalutamide for Metastatic, Castration-Sensitive Prostate Cancer.
N Engl J Med
; 381(1): 13-24, 2019 07 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31150574
19.
T-cell responses and combined immunotherapy against human carbonic anhydrase 9-expressing mouse renal cell carcinoma.
Cancer Immunol Immunother
; 71(2): 339-352, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-34160685
20.
Outcome of primary androgen deprivation therapy in super-elderly men with localized high-risk prostate cancer.
Anticancer Drugs
; 33(6): 534-538, 2022 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35276692